Related Experiment Videos

[Which one to choose for the first antihypertensive drug?]

Ilkka Tikkanen1

  • 1HYKS, medisiininen tulosyksikkö, nefrologian klinikka ja Helsinki Hypertension Centre of Excellence, PL 340, 00029 HUS.

Duodecim; Laaketieteellinen Aikakauskirja
|July 6, 2010
PubMed

Insights

All major antihypertensive drug classes improve outcomes for hypertension patients. Renin-angiotensin system inhibitors are often first-line for high-risk individuals, but drug choice requires personalized assessment.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Context:

  • Hypertension management is crucial for patient prognosis.
  • Renin-angiotensin system inhibitors are established as first-line therapy for high-risk hypertensive patients.
  • Essential hypertension is a heterogeneous condition with diverse underlying causes.

Purpose:

  • To discuss the established role of antihypertensive drug classes.
  • To highlight the individualized approach required for selecting first-line antihypertensive therapy.
  • To outline factors influencing drug selection in hypertension management.

Summary:

  • All key antihypertensive drug groups enhance patient prognosis.
  • Individualized drug selection is necessary due to hypertension's heterogeneity and diverse patient backgrounds.
  • Factors considered include potential target organ damage, associated diseases, and patient-specific blood pressure response.

Impact:

  • Optimized hypertension treatment strategies through personalized drug selection.
  • Improved patient outcomes by tailoring therapy to individual needs and risk factors.
  • Enhanced understanding of factors influencing antihypertensive drug efficacy.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...